Grifols SA - Company Profile
Powered by
All the data and insights you need on Grifols SA in one report.
- Save hours of research time and resources with
our up-to-date Grifols SA Strategy Report
- Understand Grifols SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Grifols SA Catalyst Calendar
Proactively evaluate Grifols SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Grifols SA Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Nov 2019 | Phase I/II Trial Completion | Grifols SA; JSS Medical Research Inc | GRF | fibrinogen concentrate (human) | Hematological Disorders | Afibrinogenemia | Clinical Trial Registry |
01 Oct 2019 | Phase II Trial Completion | Grifols SA | GRF | albumin (human) | Central Nervous System | Amyotrophic Lateral Sclerosis | Clinical Trial Registry |
01 Oct 2019 | Phase III Trial Initiation | Center for Sepsis Control and Care; Centre for Clinical Studies, Jena; Deutsche Forschungsgemeinschaft; German Competence Network Sepsis; German Research Foundation; Grifols SA; Jena University Hospital; Universitatsmedizin Gottingen; University of Jena | GRF | albumin (human) | Cardiovascular | Septic Shock | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer